nonyl-4-hydroxyquinoline-n-oxide has been researched along with peoniflorin in 1 studies
| Studies (nonyl-4-hydroxyquinoline-n-oxide) | Trials (nonyl-4-hydroxyquinoline-n-oxide) | Recent Studies (post-2010) (nonyl-4-hydroxyquinoline-n-oxide) | Studies (peoniflorin) | Trials (peoniflorin) | Recent Studies (post-2010) (peoniflorin) |
|---|---|---|---|---|---|
| 27 | 0 | 7 | 795 | 4 | 563 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y; Gu, YF; Hu, L; Jiang, CY; Kong, X; Liu, WT; Wu, D; Zhang, GQ; Zhang, S; Zhou, D | 1 |
1 other study(ies) available for nonyl-4-hydroxyquinoline-n-oxide and peoniflorin
| Article | Year |
|---|---|
Inhibition of apoptosis signal-regulating kinase by paeoniflorin attenuates neuroinflammation and ameliorates neuropathic pain.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Disease Models, Animal; Down-Regulation; Encephalitis; Glucosides; Hydroxyquinolines; Hyperalgesia; Interleukin-1beta; Male; MAP Kinase Kinase Kinase 5; Monoterpenes; Pain Threshold; Rats; Rats, Sprague-Dawley; Sciatic Neuropathy; Signal Transduction | 2019 |